Keyphrases
Preeclampsia
100%
Pregnant Women
52%
Exosomes
37%
During Pregnancy
37%
First Trimester
36%
Placenta
34%
Maternal Plasma
33%
Gestational Diabetes Mellitus
31%
Pregnancy Trimester
21%
Cell-free Fetal DNA
21%
Gestational Age
19%
COVID-19
18%
Selective Intrauterine Growth Restriction (sIUGR)
18%
Placental Exosomes
18%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
17%
Preterm Birth
16%
Pregnancy Complications
16%
Early Pregnancy
15%
Quantitative PCR
15%
Maternal Circulation
14%
Preeclamptic
14%
Hypoxia
14%
Placenta-derived Exosomes
14%
Fetus
14%
Endothelial Dysfunction
14%
Extracellular Vesicles
13%
Gestational Diabetes
13%
Fetal Programming
13%
Circulating Levels
12%
Non-coding RNA (ncRNA)
12%
Normal Pregnancy
11%
External Validation
11%
Omega-3 Supplements
11%
Prognostic Model
11%
Individual Participant Data Meta-analysis
11%
Endometrial Stem Cells
11%
History of Preeclampsia
11%
Meta-analysis
11%
Forkhead Box M1 (FOXM1)
11%
Ischemia
11%
Hypercholesterolemia
11%
Adverse Pregnancy Outcomes
11%
Reperfusion
11%
2-methoxyestradiol
11%
Early-onset Preeclampsia
10%
Exosomal
10%
Scavenger Receptor Class B Type 1 (SR-B1)
10%
Inflammation
10%
Ovarian Cancer
9%
Non-invasive Approach
9%
Hemolytic Disease of Fetus and Newborn
9%
Fetal DNA in Maternal Plasma
9%
High-density Lipoprotein Cholesterol (HDL-C)
9%
Birth Weight
9%
Women of Reproductive Age
9%
Fetal Growth Restriction
8%
Pregnancy Outcome
8%
Fetal Sex
8%
Fetal Growth
8%
Uterine Artery Pulsatility Index
8%
Trophoblast Invasion
8%
Prediction Model
8%
Clinical Application
8%
Uterine Artery Doppler
8%
Healthy Pregnancy
8%
Cell-derived Exosomes
8%
Lipoprotein Receptors
8%
Chemoresistance
8%
Week of Gestation
8%
Obesity
8%
Bioactivity
7%
Patients at Risk
7%
Angiogenesis
7%
Dysregulation
7%
Hemolytic Disease of the Newborn
7%
Preterm Labor
7%
Anemia
7%
Mesenchymal Stem Cells
7%
Acute Kidney Injury
7%
Tissue Plasminogen Activator (t-PA)
7%
Pregnancy Prediction
7%
Obstetrics and Gynaecology
7%
Plasma Samples
7%
Fetal Outcome
7%
Chilean
7%
Plasma Concentration
7%
Supraphysiological
6%
First-trimester Screening
6%
Early Biomarker
6%
Mitochondria
6%
Early Onset
6%
Kidney
6%
Cholesterol Metabolism
6%
Preterm Birth Risk
6%
Cholesterol
6%
Placental Ischemia
6%
Breast Cancer
6%
Preeclampsia Pathogenesis
6%
Confidence Interval
6%
Novel Biomarkers
6%
Medicine and Dentistry
Pre-Eclampsia
64%
First Trimester Pregnancy
49%
Disease
32%
Gestational Diabetes
30%
Placenta
24%
Gestational Age
21%
Premature Labor
21%
Trophoblast
19%
Biological Marker
18%
Maternal Plasma
18%
Intrauterine Growth Retardation
18%
Pregnancy
17%
Ovarian Cancer
17%
Meta-Analysis
17%
Neonatal Infant
15%
Fetus Growth
15%
Uterine Artery
14%
Case-Control Study
14%
Complication of Pregnancy
13%
Exosome
12%
Hypoxia
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Ischemia
12%
COVID-19
11%
Birth Weight
9%
Progeny
9%
Obstetrics
9%
Messenger RNA
9%
Programmed Cell Death
9%
In Vitro
8%
Diagnosis
8%
Menstrual Cycle
7%
Cancer Cell
7%
Endothelial Dysfunction
7%
Prematurity
7%
High-Density Lipoprotein
7%
Pulsatility Index
7%
Tissue Plasminogen Activator
7%
Gynecology
7%
Cohort Analysis
7%
Acute Kidney Injury
6%
Drug Resistance
6%
Stillbirth
6%
Cholesterol Metabolism
6%
Mesenchymal Stem Cell
6%
Infection
6%
Vertical Transmission
6%
Spontaneous Abortion
6%
Cross Sectional Study
6%
Angiogenesis
6%
Hemolytic Anemia
5%
Secretion (Process)
5%
Atherosclerosis
5%
microRNA 200
5%
Environmental Exposure
5%
Cell Invasion
5%
Toll Like Receptor 2
5%
Environmental Influence
5%
Atmospheric Aerosol
5%
N [3 (Aminomethyl)benzyl]acetamidine
5%
Protein Hydrolysate
5%
Obstetric Anesthesia
5%
Prenatal Diagnosis
5%
Oocyte
5%
Transcription Factor NFAT
5%
Treponema denticola
5%
Long Untranslated RNA
5%
Chorioamnionitis
5%
Maturity Onset Diabetes of the Young
5%
Heart Performance
5%
Heart Function
5%
Amnionitis
5%
Cerclage
5%
Guggulsterone
5%
Alpha Tocopherol
5%
Periodontitis
5%
Stem Cell Niche
5%
Cancer Stem Cell
5%
Tumor Microenvironment
5%
Omega-3 Fatty Acid
5%
Ischemic Heart Disease
5%
Differential Diagnosis
5%
SARS Coronavirus
5%
Antenatal Steroid
5%
Ultrafiltration
5%
Syndecan 1
5%
Matrix Metalloproteinase
5%
Fetus Lung Maturation
5%
Paclitaxel
5%
Cervix
5%
Menstruation
5%
Hippocampus
5%
Nutrition
5%
Reperfusion Injury
5%
Porphyromonas gingivalis
5%
Clinical Examination
5%
Placenta Function
5%
Hypercholesterolemia
5%
Supplementation
5%
T Lymphocyte
5%